Leonard Pinchuk
Directeur Général chez Innovia LLC
Profil
Leonard Pinchuk is the founder of Innovia LLC and InnFocus, Inc., where he holds the titles of President & Chief Executive Officer and Director & Chief Scientific Officer, respectively.
He also founded Corvita Corp.
and InnoGraft LLC.
Pinchuk's former jobs include Director at Interface Biologics, Inc. and Manager-Applied Physics & Chemistry Group at Cordis Corp.
Pinchuk received his undergraduate degree from McGill University in 1976 and his doctorate from the University of Miami in 1984.
Postes actifs de Leonard Pinchuk
| Sociétés | Poste | Début |
|---|---|---|
Innovia LLC
 Innovia LLC Medical SpecialtiesHealth Technology Innovia LLC designs and provides medical devices and polymers. It specializes in the development and manufacture of novel biomaterials and innovative medical devices. The company was founded by Leonard Pinchuk and John B. Martin in 2002 and is headquartered in Miami, FL. | Directeur Général | 01/01/2002 |
InnFocus, Inc.
 InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Fondateur | 01/01/2004 |
Anciens postes connus de Leonard Pinchuk
| Sociétés | Poste | Fin |
|---|---|---|
Corvita Corp.
 Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Fondateur | - |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Corporate Officer/Principal | - |
| InnoGraft LLC | Fondateur | - |
Interface Biologics, Inc.
 Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Formation de Leonard Pinchuk
| McGill University | Undergraduate Degree |
| University of Miami | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Corvita Corp.
Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Health Technology |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Technology Services |
Innovia LLC
Innovia LLC Medical SpecialtiesHealth Technology Innovia LLC designs and provides medical devices and polymers. It specializes in the development and manufacture of novel biomaterials and innovative medical devices. The company was founded by Leonard Pinchuk and John B. Martin in 2002 and is headquartered in Miami, FL. | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |
| InnoGraft LLC |